Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2006-11-07
2006-11-07
Minnifield, Nita (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S282100, C424S093450, C424S184100, C424S093100, C530S350000
Reexamination Certificate
active
07132102
ABSTRACT:
Novel bacteriocins and/or the novel lactic acid-producing strains are used for at least reducing the levels of colonization by at least one target bacteria in animals, especially poultry.
REFERENCES:
patent: 5733568 (1998-03-01), Ford
patent: 6403082 (2002-06-01), Stiles et al.
patent: 2004/0214304 (2004-10-01), Collins et al.
patent: 2004/0220093 (2004-11-01), Stern et al.
Thomas E. Creighton, in his book, “Proteins: Structures and Molecular Properties, 1984”, (pp. 314-315).
Thomas E. Creighton, in his book, “Protein Structure: A Practical Approach, 1989; pp. 184-186”.
Nosoh, Y. et al in “Protein Stability and Stabilization through Protein Engineering, 1991” (chapter 7, p. 197, second paragraph).
Kumar, V. et al (Amino acid variations at a single residue in an autoimmune peptide profoundly affect its properties: Immunology, 1990, 87: 1337-1341.
Kanatani, K. et al (Isolation and characterization of Acidocin A and cloning of the bacteriocin gene fromLactobacillus acidohilus, Applied and Environmental Microbiology, 1995; 61(3): 1061-1067).
Robredo, B. et al ( Bacteriocin production byLactobacillus salivariusof animal origin, Journal of Clinical Microbiology, 2000; 38(10): 3908-09).
Ocana, V. et al (Characterization of bacteriocin-like substance produced by a vaginalLactobacillus salivariusstrain, Applied and Environmental Microbiology, 1999; 65(12): 5631-5635).
Tomas, M. et al, Influence of pH temperature and culture media on the growth and bacteriocin production by vaginalLactobacillus salivariusCRL 1328, Journal of Applied Microbiology, 2002; 93: 714-724.
Gardiner, G. et al, Comparative survival rates of human-derived probioticLactobacillus paracseiandLactobacillus salivariusstrains during heat treatment and spray drying, Applied and Environmental Microbiology, 2000; 66(6): 2605-12.
Woo, P. et al, Identification by 16S rRNA gene sequencing ofLactobacillus salivariusbacteremic cholecystitis, Journal of Clinical Microbiology, 2002; 40(1): 265-267.
Silva, J. et al, Bacteriocin production by spray-dried lactic acid bacteria, Letters in Applied Microbiology, 2002; 34: 77-81.
Joosten, H., et al., “Purification and Characterization of Enterocin 4, aBacteriocin Produced by Enterococcus feccalisINIA 4”,Applied and Environmental Microbiology, vol. 62 (11), pp. 4220-4223, Nov. 1996.
Maisnier-Patin, S., et al., “Purification, Partial Characterisation and Mode of Action of Enterococcin EFS2, an Antilisterial Bacteriocin Produced by a Strain ofEnterococcus faecalisIsolated from a Cheese”,International Journal of Food Microbiology, vol. 30, pp. 255-270, 1996.
Balla, E., et al., “Characterization and Cloning of the Genes Encoding Enterocin 1071A and Enterocin 1071B, Two Antimicrobial Peptides Produced byEnterococcus faecalisBFE 1071”,Applied and Environ. Micro., vol. 66, (4), pp. 1298-1304, Apr. 2000.
Franz, C., et al., “Biochemical and Genetic Characterization of the Two-Peptide Bacteriocin Enterocin 1071 Produced byEnterococcus faecalisFAIR-E 309”,Applied and Environmental Microbiology, vol. 68, (5), pp. 2550-2554, May 2002.
Guyonnet, D., et al., “Method for Rapid Purification of Class IIa Bacteriocins and Comparison of Their Activities”,Applied and Environmental Microbiology,vol. 66, (4), pp. 1744-1748, Apr. 2000.
Juven, B., et al., “Antagonistic effects oflactobacilliandpediococcito control intestinal colonization by human enteropathogens in live poultry”,Journal of Applied Bacteriology, vol. 70, pp. 95-103, 1991.
Del Campo, R., et al., “Bacteriocin Production in Vancomycin-Resistant and Vancomycin-SusceptibleEnterococcusIsolates of Different Origins”, Abstract,Antimicrobial Agents and Chemotherapy, vol. 45, (3), pp. 905-912, Mar. 2001.
Galvez, A., et al., “Isolation and characterization of enterocin EJ97, a bacteriocin produced byEnterococcus faecalisEJ97”, Abstract,Arch Microbiol, vol. 171, pp. 59-65, 1998.
Borzenkov Valery N.
Eruslanov Boris V.
Kovalev Yuri N.
Kudryavtseva Tamara Y.
Levchuk Vladimir P.
Fado John D.
Minnifield Nita
Poulos Gail E.
State Research Center for Applied Microbiology, Ministry of Heal
The United States of America as represented by the Secretary of
LandOfFree
Bacteriocins and novel bacterial strains does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bacteriocins and novel bacterial strains, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bacteriocins and novel bacterial strains will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3633127